Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells

by Xia & He Publishing Inc.Hepatoblasts differentiate into hepatocytes, large and small cholangiocytes. CK8, CK18, and CK19 are expressed in hepatoblasts. CK8 and CK18 are expressed in hepatocytes

Updated on: July 19,2024 0

Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells

by Xia & He Publishing Inc.Hepatoblasts differentiate into hepatocytes, large and small cholangiocytes. CK8, CK18, and CK19 are expressed in hepatoblasts. CK8 and CK18 are expressed in hepatocytes

Updated on:July 19,2024 0

Research team explores etiologies of splenic venous hypertension

by Xia & He Publishing Inc.(A) Compression. Pancreatic cysts compress the splenic vein, increasing venous flow in the gastric veins and forming varices. Other causes of compression include pancrea

Updated on: July 19,2024 0

Research team explores etiologies of splenic venous hypertension

by Xia & He Publishing Inc.(A) Compression. Pancreatic cysts compress the splenic vein, increasing venous flow in the gastric veins and forming varices. Other causes of compression include pancrea

Updated on:July 19,2024 0

Proof-of-concept study demonstrates novel strategy to develop liver-targeting chimeras for disease treatment

by Liu Jia,Chinese Academy of SciencesCredit:Journal of Controlled Release(2024). DOI: 10.1016/j.jconrel.2024.08.044Liver cancer ranks as the fourth most common cancer and the second

Updated on: September 15,2024 0

Proof-of-concept study demonstrates novel strategy to develop liver-targeting chimeras for disease treatment

by Liu Jia,Chinese Academy of SciencesCredit:Journal of Controlled Release(2024). DOI: 10.1016/j.jconrel.2024.08.044Liver cancer ranks as the fourth most common cancer and the second

Updated on:September 15,2024 0

What Is Fulminant Hepatitis?

What Is Fulminant Hepatitis?ByChristine Zink, MDUpdated on September 12, 2023Medically reviewed byJordana Haber Hazan, MDHepatitisis inflammation of theliver, eithe

Updated on: July 01,2024 0

What Is Fulminant Hepatitis?

What Is Fulminant Hepatitis?ByChristine Zink, MDUpdated on September 12, 2023Medically reviewed byJordana Haber Hazan, MDHepatitisis inflammation of theliver, eithe

Updated on:July 01,2024 0

Metabolic reprogramming and HIF-1α signaling in liver fibrosis and pathological angiogenesis

Updated on: September 21,2024 0

Metabolic reprogramming and HIF-1α signaling in liver fibrosis and pathological angiogenesis

Updated on:September 21,2024 0

Cirrhosis of the Liver: Symptoms, Causes, and Treatment

Cirrhosis of the Liver: Symptoms, Causes, and TreatmentExtensive scarring caused by long-term organ injury or diseaseByCharles DanielMedically reviewed byRobert Burakoff, MDCir

Updated on: July 01,2024 0

Cirrhosis of the Liver: Symptoms, Causes, and Treatment

Cirrhosis of the Liver: Symptoms, Causes, and TreatmentExtensive scarring caused by long-term organ injury or diseaseByCharles DanielMedically reviewed byRobert Burakoff, MDCir

Updated on:July 01,2024 0

Hepatitis B: 'Sleep timer' for immune cells discovered

byTechnical University MunichA virus-specific T cell (blue) in the vascular system of a liver with chronic hepatitis B virus infection. Credit: Percy A. Knolle / TUMIn chronic hepatitis B, the l

Updated on: July 15,2024 0

Hepatitis B: 'Sleep timer' for immune cells discovered

byTechnical University MunichA virus-specific T cell (blue) in the vascular system of a liver with chronic hepatitis B virus infection. Credit: Percy A. Knolle / TUMIn chronic hepatitis B, the l

Updated on:July 15,2024 0

How to Prevent Fatty Liver Disease If You Have PCOS

How to Prevent Fatty Liver Disease If You Have PCOSByAngela Grassi, MS, RDN, LDNUpdated on July 26, 2023Medically reviewed byDo-Eun Lee, MD窗体顶端Print窗体底端Metabolic dysfunct

Updated on: July 01,2024 0

How to Prevent Fatty Liver Disease If You Have PCOS

How to Prevent Fatty Liver Disease If You Have PCOSByAngela Grassi, MS, RDN, LDNUpdated on July 26, 2023Medically reviewed byDo-Eun Lee, MD窗体顶端Print窗体底端Metabolic dysfunct

Updated on:July 01,2024 0

Study finds cirrhosis affects twice as many transgender adults as cisgender adults

byUniversity of Southern CaliforniaCredit:American Journal of Gastroenterology(2024). DOI: 10.14309/ajg.0000000000002907Cirrhosis is chronic, progressive end-stage liver disease that

Updated on: July 11,2024 0

Study finds cirrhosis affects twice as many transgender adults as cisgender adults

byUniversity of Southern CaliforniaCredit:American Journal of Gastroenterology(2024). DOI: 10.14309/ajg.0000000000002907Cirrhosis is chronic, progressive end-stage liver disease that

Updated on:July 11,2024 0

CDC: Prevalence of any past, present hep B infection 4.3 percent

(HealthDay)—The prevalence of any past or present hepatitis B virus (HBV) infection was 4.3 percent among U.S. adults during 2015 to 2018, according to a March data brief published by the U.S. Centers

Updated on: June 12,2024 5

CDC: Prevalence of any past, present hep B infection 4.3 percent

(HealthDay)—The prevalence of any past or present hepatitis B virus (HBV) infection was 4.3 percent among U.S. adults during 2015 to 2018, according to a March data brief published by the U.S. Centers

Updated on:June 12,2024 5

Gut microbiota harnessed as tool to diagnose diseases, promising results for fatty liver diagnosis

by University of JyväskyläThe diversity of the gut microbiota in the low (n = 25) and high (n = 37) liver fat groups. (A) Shannon index, a measure of alpha-diversity indicating species diversity.

Updated on: May 29,2024 4

Gut microbiota harnessed as tool to diagnose diseases, promising results for fatty liver diagnosis

by University of JyväskyläThe diversity of the gut microbiota in the low (n = 25) and high (n = 37) liver fat groups. (A) Shannon index, a measure of alpha-diversity indicating species diversity.

Updated on:May 29,2024 4

Immune therapies against chronic hepatitis B

by Ehime UniversityTwo main types of immune therapies have been employed to treat chronic hepatitis B during the last 4 decades. However, it seems that HBV-antigen-specific immune therapy may be safe

Updated on: May 29,2024 7

Immune therapies against chronic hepatitis B

by Ehime UniversityTwo main types of immune therapies have been employed to treat chronic hepatitis B during the last 4 decades. However, it seems that HBV-antigen-specific immune therapy may be safe

Updated on:May 29,2024 7